|
Yale Cancer Biology Training Grant
|
5T32CA193200-03
|
$229,769
|
|
GLAZER, PETER
|
YALE UNIVERSITY
|
|
Whole-of-Community Systems Intervention for Youth Population Physical Activity
|
1R01CA215420-01A1
|
$512,891
|
|
DZEWALTOWSKI, DAVID
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
|
5K12CA167540-07
|
$810,000
|
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer
|
1R01CA214606-01A1
|
$370,707
|
|
RODRIGUEZ, GUSTAVO
|
NORTHSHORE UNIVERSITY HEALTHSYSTEM
|
|
Validation and translation of a non-invasive, MR-guided breast cancer therapy
|
1R37CA224141-01
|
$513,511
|
|
PAYNE, ALLISON
|
UNIVERSITY OF UTAH
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
5R21CA208921-02
|
$167,475
|
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,788,723
|
$89,436
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Unlocking the Potential of PI3K Inhibition in CLL
|
5R01CA213442-02
|
$596,117
|
|
BROWN, JENNIFER
|
DANA-FARBER CANCER INST
|
|
University of Virginia Cancer Center Support Grant
|
2P30CA044579-26
|
$2,574,504
|
$25,745
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S1
|
$125,000
|
$1,250
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S2
|
$104,087
|
$1,041
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
Understanding Uncertainties in Radiomics Studies
|
5R21CA216572-02
|
$139,200
|
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism
|
5R01CA204969-02
|
$320,959
|
|
NAGRATH, DEEPAK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Translation addiction and targeting in colon cancer
|
1R01CA215481-01A1
|
$467,690
|
|
YU, JIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Towards the automation of MR spectroscopic imaging in patients with glioblashoma
|
5F30CA206291-03
|
$49,524
|
|
GURBANI, SAUMYA
|
EMORY UNIVERSITY
|
|
Tissue Processing-Sequencing Facility
|
ZIC BC 011044
|
$651,382
|
$13,028
|
Vocke, Cathy
|
CCR (NCI)
|
|
The Role of STAT2 in Flat Non-Polypoid Colorectal Neoplasia
|
5R03CA215929-02
|
$78,000
|
|
GAMERO, ANA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
The Role of JAK2 in ILEI-Induced Cancer Stem Cell Formation
|
5F30CA203269-03
|
$46,154
|
|
NOGUCHI, KEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
The role of gene enhancer elements in colon cancer
|
2R01CA160356-06
|
$366,669
|
|
SCACHERI, PETER
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
|
1R37CA214609-01A1
|
$366,000
|
|
GIBBONS, DON
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The Role of DLST in Leukemogenesis
|
1R01CA215059-01A1
|
$377,437
|
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The Myc - miR-17-92 axis in colorectal cancers
|
5R01CA196299-04
|
$384,300
|
|
THOMAS-TIKHONENKO, ANDREI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase.
|
5R01CA214608-02
|
$410,426
|
|
FISCHER, ERIC
|
DANA-FARBER CANCER INST
|
|
The Lifecycle of Health Data: Polices and Practices
|
1R01CA214829-01A1
|
$621,572
|
|
KARDIA, SHARON
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The Impact of Tobacco Control Policies on Health Equity in the United States
|
1R37CA214787-01A1
|
$518,400
|
|
FLEISCHER, NANCY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The epigenetic mechanism of long non-coding RNA in cancer
|
5R01CA190415-04
|
$366,000
|
|
ZHANG, LIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
The E2F1 Post-Translational Modification Code
|
1R01CA214723-01A1
|
$444,362
|
|
JOHNSON, DAVID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab
|
5R01CA204167-03
|
$674,466
|
|
LEWIS, JASON
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Testicular cancer among US Servicemen
|
ZIA CP010126-01202
|
$12,070
|
$12,070
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
TECAC
|
ZIA CP010126-10533
|
$18,356
|
$18,356
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Targeting ROS production in OXPHOS-defective and OXPHOS-competent tumors
|
1R01CA215410-01A1
|
$513,278
|
|
YEH, JING-RUEY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting Multiple Myeloma with Smac-mimetics and HDAC Inhibitors
|
5R01CA205607-03
|
$313,959
|
|
GRANT, STEVEN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Targeting Metabolic Liabilities in Cancer
|
1R01CA214948-01A1
|
$390,657
|
|
POSSEMATO, RICHARD
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Targeting lymph node metastases to prevent cancer progression
|
5R01CA214913-02
|
$384,094
|
|
PADERA, TIMOTHY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting KDM4B, a novel alternative splicing regulator, in castration-resistant prostate cancer (CRPC)
|
1R01CA215063-01A1
|
$429,276
|
|
LIU, ZHI-PING
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Targeting DNA Base Excision Repair in Acute Myeloid Leukemias
|
5R21CA216551-02
|
$167,475
|
|
LLOYD, R
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics
|
5R01CA185169-05
|
$475,351
|
|
MCKNIGHT, STEVEN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Targeting Abl kinases in BRAF-driven melanomas
|
1R01CA211137-01A1
|
$343,683
|
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
T antigens inhibit Notch to promote Merkel cell carcinoma in skin stem cells
|
5F31CA213464-02
|
$32,060
|
|
PARK, DONGLIM
|
HARVARD MEDICAL SCHOOL
|
|
Systemic RNA interference to reactivate p53 tumor suppression
|
5R01CA208783-02
|
$361,766
|
|
STEGH, ALEXANDER
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Synthesizing Image-derived Heterogeneity with Genomic measurements for Assessing Disease Aggressiveness in Lower Grade Gliomas
|
1R37CA214955-01A1
|
$35,692
|
|
RAO, ARVIND
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Synergy of Radiation and Immunotherapy: New Approaches
|
5R01CA134563-10
|
$384,750
|
|
FU, YANG-XIN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
SWOG Statistics and Data Management Center
|
5U10CA180819-05
|
$7,938,884
|
|
LEBLANC, MICHAEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Studies to understand and exploit 10-membered enediyne biosynthesis
|
5R01CA217255-02
|
$516,179
|
|
THORSON, JON
|
UNIVERSITY OF KENTUCKY
|
|
Studies in the Janus Cohort
|
ZIA CP010120-02135
|
$37,812
|
$3,403
|
Rothman, Nat
|
DCEG (NCI)
|
|
Structure and function of genome plasticity in human cancer
|
1R01CA214812-01A1
|
$497,179
|
|
KENTSIS, ALEX
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Stimulated Raman scattering spectroscopic optical coherence tomography (SRS-SOCT) for label-free molecular imaging of brain tumor pathology
|
1R21CA223853-01
|
$189,117
|
|
ROBLES, FRANCISCO
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
Stem cell self-renewal programs in rhabdomyosarcoma
|
1R01CA215118-01A1
|
$385,444
|
|
LANGENAU, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Testes for this search: $2,876,459
|